Crossmark

Development of a hyperosmolar-hyperglycemic state and possible fulminant type 1 diabetes mellitus during the treatment of a case of adenocarcinoma of the lung and interstitial pneumonia

Crossref DOI link: https://doi.org/10.1007/s13340-022-00579-w

Published Online: 2022-03-30

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Onishi, Kasumi

Baba, Natsuki

Nagai, So

Yasui, Ayano

Iesaka, Hiroshi

Endo, Mikiko

Yoshioka, Narihito
License Information

Text and Data Mining valid from 2022-03-30

Version of Record valid from 2022-03-30
More Information

Article History

Received: 7 December 2021

Accepted: 10 March 2022

First Online: 30 March 2022

Declarations

:

: S.N. has received honoraria for lectures from Eli Lilly. N.Y. has received honoraria for lectures from Novo Nordisk Pharma and Takeda Pharmaceutical Co., Ltd. K.O., N.B., A.Y., H.I. and M.E. have nothing to disclose.

: This article does not contain any studies with human or animal subjects performed by any of the authors. All procedures followed were in accordance with the Helsinki Declaration of 1964 and later versions. Written informed consent was obtained from the patient for publication of this case report.

Document is current

Any future updates will be listed below